← Open Payments lookup

ROHIDAS PATIL: Open Payments

NPI 1871601989 · DECATUR, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,086 in 47 payments from 10 companies in 2025. Trend: 2023 $1,780 · 2024 $1,447 · 2025 $1,086

Food & beverage: $1,086
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.14$328
Alkermes, Inc.9$226
Neurocrine BioSciences, Inc.8$200
E.R. Squibb & Sons, L.L.C.5$110
Janssen Pharmaceuticals, Inc5$107
Axsome Therapeutics, Inc.2$46
Lundbeck LLC1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Corium, LLC1$15
Lilly USA, LLC1$15

Products named: ARISTADA, INGREZZA, REXULTI, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, Sunosi, ABILIFY MAINTENA.

Industry payments across IL — which companies pay providers there.